Literature DB >> 21153181

Pituitary-adrenal axis function in systemic inflammatory response syndrome.

J A Tayek1, V J Atienza.   

Abstract

This study characterizes the hypothalamic-pituitary-adrenal axis function in patients with sepsis syndrome now known as systemic inflammatory response syndrome (SIRS). One hundred and thirteen patients with SIRS had their pituitary-adrenal axis tested with the use of a 250 µg IV ACTH stimulation test. No patient received corticosteroids prior to the ACTH stimulation test. Serum cortisol concentrations were measured prior to and 30 and 60 min after ACTH administration. 26% of the patients had bacteremia, 22% bacteruria, 22% AIDS, 17% renal failure, 15% diabetes, 13% severe liver disease, 8% GI bleed, 4% pancreatitis, 3% trauma and 1% classical Addison's disease. Several patients had more than one disorder. The overall mortality was 28%. Multivariate analysis identified that both the baseline cortisol concentration and delta cortisol concentration were significant indicators of mortality. Despite the fact that mortality was double in the bacteremic patients, the baseline cortisol concentrations were similar to the non-bacteremic patients (25.4 ± 1.9vs 25.1 ± 2.5 µg/dl). The only cortisol abnormality noted in the bacteremic patients was a significantly smaller delta cortisol response to ACTH (14.7 ± 2.2vs 18.9 ± 1.2 µg/dl;P<0.05). These data imply that bacteremic processes may alter the adrenal responsiveness to intravenous ACTH administration. Understanding the pathophysiological disturbances responsible for an impaired adrenal reserve may identify new treatment strategies for patients with bacteremia.

Entities:  

Year:  1995        PMID: 21153181     DOI: 10.1007/BF03021412

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  25 in total

1.  Metabolism of adrenal steroids in dying patients.

Authors:  A A SANDBERG; K EIK-NES; C J MIGEON; L T SAMUELS
Journal:  J Clin Endocrinol Metab       Date:  1956-08       Impact factor: 5.958

2.  Spectrum of serum cortisol response to ACTH in ICU patients. Correlation with degree of illness and mortality.

Authors:  T H Jurney; J L Cockrell; J S Lindberg; J M Lamiell; C E Wade
Journal:  Chest       Date:  1987-08       Impact factor: 9.410

3.  Plasma cortisol determination: radioimmunoassay and competitive protein binding compared.

Authors:  R W Farmer; C E Pierce
Journal:  Clin Chem       Date:  1974-04       Impact factor: 8.327

4.  Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors.

Authors:  R C Gaillard; D Turnill; P Sappino; A F Muller
Journal:  Endocrinology       Date:  1990-07       Impact factor: 4.736

5.  Intrahypothalamic perfusion with interleukin-1-beta stimulates the local release of corticotropin-releasing hormone and arginine vasopressin and the plasma adrenocorticotropin in freely moving rats: a comparative perfusion of the paraventricular nucleus and the median eminence.

Authors:  H Watanobe; K Takebe
Journal:  Neuroendocrinology       Date:  1993-04       Impact factor: 4.914

6.  Distribution and characterization of immunoreactive corticostatin in the hypothalamic-pituitary-adrenal axis.

Authors:  T Tominaga; J Fukata; Y Hayashi; Y Satoh; N Fuse; H Segawa; O Ebisui; Y Nakai; Y Osamura; H Imura
Journal:  Endocrinology       Date:  1992-03       Impact factor: 4.736

7.  Transient corticotropin deficiency in critical illness.

Authors:  A I Kidess; R H Caplan; R H Reynertson; G G Wickus; D E Goodnough
Journal:  Mayo Clin Proc       Date:  1993-05       Impact factor: 7.616

8.  Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo.

Authors:  R S Perlstein; M H Whitnall; J S Abrams; E H Mougey; R Neta
Journal:  Endocrinology       Date:  1993-03       Impact factor: 4.736

9.  Adrenal function in patients with active tuberculosis.

Authors:  D J Barnes; S Naraqi; P Temu; J R Turtle
Journal:  Thorax       Date:  1989-05       Impact factor: 9.139

10.  Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings.

Authors:  H R Michie; D R Spriggs; K R Manogue; M L Sherman; A Revhaug; S T O'Dwyer; K Arthur; C A Dinarello; A Cerami; S M Wolff
Journal:  Surgery       Date:  1988-08       Impact factor: 3.982

View more
  5 in total

Review 1.  Hydrocortisone and the reduction of vasopressors in septic shock: therapy or only chart cosmetics?

Authors:  J Briegel
Journal:  Intensive Care Med       Date:  2000-12       Impact factor: 17.440

Review 2.  [Cortisone substitution in sepsis. Is less more?].

Authors:  J Briegel
Journal:  Anaesthesist       Date:  2003-12       Impact factor: 1.041

3.  Risk factors of relative adrenocortical deficiency in intensive care patients needing mechanical ventilation.

Authors:  Gabriel Malerba; Florence Romano-Girard; Aurélie Cravoisy; Brigitte Dousset; Lionel Nace; Bruno Lévy; Pierre-Edouard Bollaert
Journal:  Intensive Care Med       Date:  2005-02-10       Impact factor: 17.440

Review 4.  [Corticosteroid insufficiency in the critically ill. Pathomechanisms and recommendations for diagnosis and treatment].

Authors:  J Briegel; M Vogeser; D Keh; P Marik
Journal:  Anaesthesist       Date:  2009-02       Impact factor: 1.041

5.  A prospective study on adrenal cortex responses and outcome prediction in acute critical illness: results from a large cohort of 203 mixed ICU patients.

Authors:  Ioanna Dimopoulou; Konstantinos Stamoulis; Ioannis Ilias; Marinella Tzanela; Panagiotis Lyberopoulos; Stylianos Orfanos; Apostolos Armaganidis; Maria Theodorakopoulou; Stylianos Tsagarakis
Journal:  Intensive Care Med       Date:  2007-08-08       Impact factor: 17.440

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.